Novartis AG (NOT) Stock Price & News

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024. Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others. Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes. After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia

About Novartis AG

CEOVasant Narasimhan

Employees75.3 ሺ

Founded7 ማርች 1996

Headquartersባዝል, Basel City, ስዊዘርላንድ

SectorPharmaceutical industry

Websitenovartis.com

All values in USD	ሴፕቴ 2025	ዲሴም 2025	ማርች 2026	ጁን 2026
Revenue	14.36 ቢ	13.86 ቢ	13.52 ቢ	14.95 ቢ
Cost of goods sold	3.54 ቢ	3.54 ቢ	3.44 ቢ	3.68 ቢ
Cost of revenue	3.54 ቢ	3.54 ቢ	3.44 ቢ	3.68 ቢ
Research and development expenses	2.86 ቢ	2.84 ቢ	2.78 ቢ	2.74 ቢ
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.30 ቢ	3.44 ቢ	3.14 ቢ	3.23 ቢ
Operating expense	6.24 ቢ	6.46 ቢ	5.96 ቢ	6.10 ቢ
Total operating expenses	9.77 ቢ	10.00 ቢ	9.40 ቢ	9.78 ቢ
Operating income	4.58 ቢ	3.86 ቢ	4.12 ቢ	5.18 ቢ
Other non operating income	-7.00 ሚ	-130.00 ሚ	4.00 ሚ	19.00 ሚ
EBT including unusual items	4.20 ቢ	3.22 ቢ	3.84 ቢ	4.27 ቢ
EBT excluding unusual items	4.29 ቢ	3.49 ቢ	3.78 ቢ	4.73 ቢ
Income tax expense	266.00 ሚ	814.00 ሚ	683.00 ሚ	1.01 ቢ
Effective tax rate	6.34%	25.30%	17.79%	23.71%
Other operating expenses	70.00 ሚ	190.00 ሚ	42.00 ሚ	127.00 ሚ
Net income	3.93 ቢ	2.41 ቢ	3.16 ቢ	3.26 ቢ
Net profit margin	27.36%	17.38%	23.34%	21.83%
Earnings per share	2.25	2.03	1.99	2.41
Interest and investment income	-	373.00 ሚ	-	-
Interest expense	-281.00 ሚ	-304.00 ሚ	-343.00 ሚ	-462.00 ሚ
Net interest expenses	-281.00 ሚ	69.00 ሚ	-343.00 ሚ	-462.00 ሚ
Depreciation and amortization charges	-	-	-	-
EBITDA	5.78 ቢ	4.96 ቢ	5.24 ቢ	6.30 ቢ
Gain or loss from assets sale	81.00 ሚ	80.00 ሚ	-159.00 ሚ	-247.00 ሚ

Ask anything